Genix Acquires 30 Ophthalmic Dossiers In Canada

Expects To Begin Commercialization From 2022

 
• By David Wallace
  
Canada
Genix has acquired 30 ophthalmic generics dossiers for the Canadian market • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Deals

More from Business